2016
Y. Zhan, Ma, J., Alexander-Bloch, A. F., Xu, K., Cui, Y., Feng, Q., Jiang, T., and Liu, Y.,
“Longitudinal Study of Impaired Intra- and Inter-Network Brain Connectivity in Subjects at High Risk for Alzheimer's Disease.”,
J Alzheimers Dis, vol. 52, no. 3, pp. 913-27, 2016.
J. - S. Vidal, Hanon, O., Funalot, B., Brunel, N., Viollet, C., Rigaud, A. - S., Seux, M. - L., le-Bouc, Y., Epelbaum, J., and Duron, E.,
“Low Serum Insulin-Like Growth Factor-I Predicts Cognitive Decline in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 52, no. 2, pp. 641-9, 2016.
F. Huang, Shang, Y., Luo, Y., Wu, P., Huang, X., Tan, X., Lu, X., Zhen, L., and Hu, X.,
“Lower Prevalence of Alzheimer's Disease among Tibetans: Association with Religious and Genetic Factors.”,
J Alzheimers Dis, vol. 50, no. 3, pp. 659-67, 2016.
F. Huang, Shang, Y., Luo, Y., Wu, P., Huang, X., Tan, X., Lu, X., Zhen, L., and Hu, X.,
“Lower Prevalence of Alzheimer's Disease among Tibetans: Association with Religious and Genetic Factors.”,
J Alzheimers Dis, vol. 50, no. 3, pp. 659-67, 2016.
E. C. Pinnock, Jovanovic, K., Pinto, M. G., Ferreira, E., Dias, B. Da Costa, Penny, C., Knackmuss, S., Reusch, U., Little, M., Schatzl, H. M., and Weiss, S. F. T.,
“LRP/LR Antibody Mediated Rescuing of Amyloid-β-Induced Cytotoxicity is Dependent on PrPc in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 49, no. 3, pp. 645-57, 2016.
D. Zhu, Yang, N., Liu, Y. - Y., Zheng, J., Ji, C., and Zuo, P. - P.,
“M2 Macrophage Transplantation Ameliorates Cognitive Dysfunction in Amyloid-β-Treated Rats Through Regulation of Microglial Polarization.”,
J Alzheimers Dis, vol. 52, no. 2, pp. 483-95, 2016.
R. Remington, Bechtel, C., Larsen, D., Samar, A., Page, R., Morrell, C., and Shea, T. B.,
“Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.”,
J Alzheimers Dis, vol. 51, no. 4, pp. 991-5, 2016.
P. Pastor, Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munain, A. López, Bullido, M. J., de Pancorbo, M. M., Carro, E., Antonell, A., Coto, E., Ortega-Cubero, S., Hernandez, I., Tárraga, L., Boada, M., Lleo, A., Dols-Icardo, O., Kulisevsky, J., Vázquez-Higuera, J. Luis, Infante, J., Rábano, A., Fernández-Blázquez, M. Ángel, Valentí, M., Indakoetxea, B., Barandiarán, M., Gorostidi, A., Frank-García, A., Sastre, I., Lorenzo, E., Pastor, M. A., Elcoroaristizabal, X., Lennarz, M., Maier, W., Rámirez, A., Serrano-Ríos, M., Lee, S. E., and Sánchez-Juan, P.,
“MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.”,
J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
P. Pastor, Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munain, A. López, Bullido, M. J., de Pancorbo, M. M., Carro, E., Antonell, A., Coto, E., Ortega-Cubero, S., Hernandez, I., Tárraga, L., Boada, M., Lleo, A., Dols-Icardo, O., Kulisevsky, J., Vázquez-Higuera, J. Luis, Infante, J., Rábano, A., Fernández-Blázquez, M. Ángel, Valentí, M., Indakoetxea, B., Barandiarán, M., Gorostidi, A., Frank-García, A., Sastre, I., Lorenzo, E., Pastor, M. A., Elcoroaristizabal, X., Lennarz, M., Maier, W., Rámirez, A., Serrano-Ríos, M., Lee, S. E., and Sánchez-Juan, P.,
“MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.”,
J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
P. Pastor, Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munain, A. López, Bullido, M. J., de Pancorbo, M. M., Carro, E., Antonell, A., Coto, E., Ortega-Cubero, S., Hernandez, I., Tárraga, L., Boada, M., Lleo, A., Dols-Icardo, O., Kulisevsky, J., Vázquez-Higuera, J. Luis, Infante, J., Rábano, A., Fernández-Blázquez, M. Ángel, Valentí, M., Indakoetxea, B., Barandiarán, M., Gorostidi, A., Frank-García, A., Sastre, I., Lorenzo, E., Pastor, M. A., Elcoroaristizabal, X., Lennarz, M., Maier, W., Rámirez, A., Serrano-Ríos, M., Lee, S. E., and Sánchez-Juan, P.,
“MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.”,
J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
P. Pastor, Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munain, A. López, Bullido, M. J., de Pancorbo, M. M., Carro, E., Antonell, A., Coto, E., Ortega-Cubero, S., Hernandez, I., Tárraga, L., Boada, M., Lleo, A., Dols-Icardo, O., Kulisevsky, J., Vázquez-Higuera, J. Luis, Infante, J., Rábano, A., Fernández-Blázquez, M. Ángel, Valentí, M., Indakoetxea, B., Barandiarán, M., Gorostidi, A., Frank-García, A., Sastre, I., Lorenzo, E., Pastor, M. A., Elcoroaristizabal, X., Lennarz, M., Maier, W., Rámirez, A., Serrano-Ríos, M., Lee, S. E., and Sánchez-Juan, P.,
“MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.”,
J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
W. B. Mowrey, Lipton, R. B., Katz, M. J., Ramratan, W. S., Loewenstein, D. A., Zimmerman, M. E., and Buschke, H.,
“Memory Binding Test Predicts Incident Amnestic Mild Cognitive Impairment.”,
J Alzheimers Dis, vol. 53, no. 4, pp. 1585-95, 2016.
W. B. Mowrey, Lipton, R. B., Katz, M. J., Ramratan, W. S., Loewenstein, D. A., Zimmerman, M. E., and Buschke, H.,
“Memory Binding Test Predicts Incident Amnestic Mild Cognitive Impairment.”,
J Alzheimers Dis, vol. 53, no. 4, pp. 1585-95, 2016.
R. Langlois, Joubert, S., Benoit, S., Dostie, V., and Rouleau, I.,
“Memory for Public Events in Mild Cognitive Impairment and Alzheimer's Disease: The Importance of Rehearsal.”,
J Alzheimers Dis, vol. 50, no. 4, pp. 1023-33, 2016.
K. Steenland, Goldstein, F. C., Levey, A., and Wharton, W.,
“A Meta-Analysis of Alzheimer's Disease Incidence and Prevalence Comparing African-Americans and Caucasians.”,
J Alzheimers Dis, vol. 50, no. 1, pp. 71-6, 2016.
J. A. Luchsinger, Perez, T., Chang, H., Mehta, P., Steffener, J., Pradabhan, G., Ichise, M., Manly, J., Devanand, D. P., and Bagiella, E.,
“Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial.”,
J Alzheimers Dis, vol. 51, no. 2, pp. 501-14, 2016.
H. Li, Jia, J., and Yang, Z.,
“Mini-Mental State Examination in Elderly Chinese: A Population-Based Normative Study.”,
J Alzheimers Dis, vol. 53, no. 2, pp. 487-96, 2016.
H. - H. Li, Lin, S. - L., Huang, C. - N., Lu, F. - J., Chiu, P. - Y., Huang, W. - N., Lai, T. - J., and Lin, C. - L.,
“miR-302 Attenuates Amyloid-β-Induced Neurotoxicity through Activation of Akt Signaling.”,
J Alzheimers Dis, vol. 50, no. 4, pp. 1083-98, 2016.
H. - H. Li, Lin, S. - L., Huang, C. - N., Lu, F. - J., Chiu, P. - Y., Huang, W. - N., Lai, T. - J., and Lin, C. - L.,
“miR-302 Attenuates Amyloid-β-Induced Neurotoxicity through Activation of Akt Signaling.”,
J Alzheimers Dis, vol. 50, no. 4, pp. 1083-98, 2016.
H. - H. Li, Lin, S. - L., Huang, C. - N., Lu, F. - J., Chiu, P. - Y., Huang, W. - N., Lai, T. - J., and Lin, C. - L.,
“miR-302 Attenuates Amyloid-β-Induced Neurotoxicity through Activation of Akt Signaling.”,
J Alzheimers Dis, vol. 50, no. 4, pp. 1083-98, 2016.
H. - H. Li, Lin, S. - L., Huang, C. - N., Lu, F. - J., Chiu, P. - Y., Huang, W. - N., Lai, T. - J., and Lin, C. - L.,
“miR-302 Attenuates Amyloid-β-Induced Neurotoxicity through Activation of Akt Signaling.”,
J Alzheimers Dis, vol. 50, no. 4, pp. 1083-98, 2016.
H. - H. Li, Lin, S. - L., Huang, C. - N., Lu, F. - J., Chiu, P. - Y., Huang, W. - N., Lai, T. - J., and Lin, C. - L.,
“miR-302 Attenuates Amyloid-β-Induced Neurotoxicity through Activation of Akt Signaling.”,
J Alzheimers Dis, vol. 50, no. 4, pp. 1083-98, 2016.
K. Hoffmann, Sobol, N. A., Frederiksen, K. S., Beyer, N., Vogel, A., Vestergaard, K., Brændgaard, H., Gottrup, H., Lolk, A., Wermuth, L., Jacobsen, S., Laugesen, L. P., Gergelyffy, R. G., Høgh, P., Bjerregaard, E., Andersen, B. B., Siersma, V., Johannsen, P., Cotman, C. W., Waldemar, G., and Hasselbalch, S. G.,
“Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial.”,
J Alzheimers Dis, vol. 50, no. 2, pp. 443-53, 2016.
K. Hoffmann, Sobol, N. A., Frederiksen, K. S., Beyer, N., Vogel, A., Vestergaard, K., Brændgaard, H., Gottrup, H., Lolk, A., Wermuth, L., Jacobsen, S., Laugesen, L. P., Gergelyffy, R. G., Høgh, P., Bjerregaard, E., Andersen, B. B., Siersma, V., Johannsen, P., Cotman, C. W., Waldemar, G., and Hasselbalch, S. G.,
“Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial.”,
J Alzheimers Dis, vol. 50, no. 2, pp. 443-53, 2016.
M. Zhu, Huang, C., Ma, X., Wu, R., Zhu, W., Li, X., Liang, Z., Deng, F., Zhu, J., Xie, W., Yang, X., Jiang, Y., Wang, S., Wu, J., Geng, S., Xie, C., and Zhong, C.,
“Modulation of miR-19 in Aluminum-Induced Neural Cell Apoptosis.”,
J Alzheimers Dis, vol. 50, no. 4, pp. 1149-62, 2016.
] 